Chairperson’s Address to Clarity’s Annual General Meeting 2025
Sydney, Australia 25 November 2025 Clarity Pharmaceuticals (ASX: CU6) (“Clarity” or “Company”), a clinical-stage radiopharmaceutical company developing next-generation products to address the growing needs in oncology, is pleased to provide the Chairperson’s Address to the Annual General Meeting of Shareholders being held at 10:00am, 25th of November 2025. Good morning, everyone, Welcome to what is…